VistaGen TherapeuticsVTGN 
$3.191.27%24h
1.27%24h
Global rank22045
Market cap$22.20M
Change 7d-3.04%
YTD Performance-36.83%
SP500 benchmarkUnderperform
P/E-0.37
P/S-97.67
Revenue-$227.30K
Earnings-$59.25M
Dividend yield-
Main Sector
Healthcare
Category
VistaGen Therapeutics VTGN Earnings
Earnings in 2023: $-59.25M
According to VistaGen Therapeutics latest financial reports the company had earnings of $-59.25M in 2023-03-31, an increase of 24.05% to 2022.
VistaGen Therapeutics Earnings History from 2020 to 2024
-
Value:-
VistaGen Therapeutics Annual Earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 | -$59.25M | 24.05% |
| 2022 | -$47.76M | 166.32% |
| 2021 | -$17.93M | -13.67% |
| 2020 | -$20.77M | - |
View the top earning stocks 
